1887

Abstract

Prion diseases are fatal neurodegenerative disorders of humans and animals and no effective treatments are currently available. Allogenic transplantation of immortalized human mesenchymal stem cells (MSCs) can prolong the survival of mice infected with prions. However, autologous transplantation is an appropriate model for evaluating the effects of MSCs on prion diseases. Therefore, we isolated and purified MSCs from the femur and tibia of mice as compact bone-derived MSCs (CB-MSCs). Flow cytometric analysis showed that CB-MSCs were negative for myeloid stem cell-derived cell markers CD11b and CD45, but positive for molecules such as Sca-1, CD105 and CD90.2, which are reported to be expressed on MSCs. The ability of CB-MSCs to migrate to brain extracts from prion-infected mice was confirmed by an in vitro migration assay. Intra-hippocampus transplantation of CB-MSCs at 120 days post-inoculation marginally but significantly prolonged the survival of mice infected with the Chandler prion strain. The transplantation of CB-MSCs did not influence the accumulation of disease-specific prion protein. However, the CB-MSC transplantation enhanced microglial activation, which appeared to be polarized to the M2-type activation state. These results suggest that autologous MSC transplantation is a possible treatment for prion diseases, while the modification of microglial activation may be a therapeutic target for neurodegenerative diseases.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/jgv.0.000907
2017-09-06
2019-10-21
Loading full text...

Full text loading...

/deliver/fulltext/jgv/98/10/2615.html?itemId=/content/journal/jgv/10.1099/jgv.0.000907&mimeType=html&fmt=ahah

References

  1. Prusiner SB. Prions. Proc Natl Acad Sci USA 1998; 95: 13363– 13383 [PubMed] [Crossref]
    [Google Scholar]
  2. Nombela-Arrieta C, Ritz J, Silberstein LE. The elusive nature and function of mesenchymal stem cells. Nat Rev Mol Cell Biol 2011; 12: 126– 131 [CrossRef] [PubMed]
    [Google Scholar]
  3. Kuroda Y, Kitada M, Wakao S, Dezawa M. Bone marrow mesenchymal cells: how do they contribute to tissue repair and are they really stem cells?. Arch Immunol Ther Exp 2011; 59: 369– 378 [CrossRef]
    [Google Scholar]
  4. Snykers S, de Kock J, Rogiers V, Vanhaecke T. In vitro differentiation of embryonic and adult stem cells into hepatocytes: state of the art. Stem Cells 2009; 27: 577– 605 [CrossRef] [PubMed]
    [Google Scholar]
  5. Qayyum AA, Haack-Sørensen M, Mathiasen AB, Jørgensen E, Ekblond A et al. Adipose-derived mesenchymal stromal cells for chronic myocardial ischemia (MyStromalCell Trial): study design. Regen Med 2012; 7: 421– 428 [CrossRef] [PubMed]
    [Google Scholar]
  6. Qi Y, Feng G, Yan W. Mesenchymal stem cell-based treatment for cartilage defects in osteoarthritis. Mol Biol Rep 2012; 39: 5683– 5689 [CrossRef] [PubMed]
    [Google Scholar]
  7. Chen J, Li Y, Wang L, Lu M, Zhang X et al. Therapeutic benefit of intracerebral transplantation of bone marrow stromal cells after cerebral ischemia in rats. J Neurol Sci 2001; 189: 49– 57 [CrossRef] [PubMed]
    [Google Scholar]
  8. Li Y, Chen J, Zhang CL, Wang L, Lu D et al. Gliosis and brain remodeling after treatment of stroke in rats with marrow stromal cells. Glia 2005; 49: 407– 417 [CrossRef] [PubMed]
    [Google Scholar]
  9. Hofstetter CP, Schwarz EJ, Hess D, Widenfalk J, El Manira A et al. Marrow stromal cells form guiding strands in the injured spinal cord and promote recovery. Proc Natl Acad Sci USA 2002; 99: 2199– 2204 [CrossRef] [PubMed]
    [Google Scholar]
  10. Nakamura K, Ito Y, Kawano Y, Kurozumi K, Kobune M et al. Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model. Gene Ther 2004; 11: 1155– 1164 [CrossRef] [PubMed]
    [Google Scholar]
  11. Lee JK, Jin HK, Endo S, Schuchman EH, Carter JE et al. Intracerebral transplantation of bone marrow-derived mesenchymal stem cells reduces amyloid-beta deposition and rescues memory deficits in Alzheimer's disease mice by modulation of immune responses. Stem Cells 2010; 28: 329– 343 [CrossRef] [PubMed]
    [Google Scholar]
  12. Kim S, Chang KA, Kim J, Park HG, Ra JC et al. The preventive and therapeutic effects of intravenous human adipose-derived stem cells in Alzheimer's disease mice. PLoS One 2012; 7: e45757 [CrossRef] [PubMed]
    [Google Scholar]
  13. Hellmann MA, Panet H, Barhum Y, Melamed E, Offen D. Increased survival and migration of engrafted mesenchymal bone marrow stem cells in 6-hydroxydopamine-lesioned rodents. Neurosci Lett 2006; 395: 124– 128 [CrossRef] [PubMed]
    [Google Scholar]
  14. Blandini F, Cova L, Armentero MT, Zennaro E, Levandis G et al. Transplantation of undifferentiated human mesenchymal stem cells protects against 6-hydroxydopamine neurotoxicity in the rat. Cell Transplant 2010; 19: 203– 218 [CrossRef] [PubMed]
    [Google Scholar]
  15. Park HJ, Shin JY, Lee BR, Kim HO, Lee PH. Mesenchymal stem cells augment neurogenesis in the subventricular zone and enhance differentiation of neural precursor cells into dopaminergic neurons in the substantia nigra of a parkinsonian model. Cell Transplant 2012; 21: 1629– 1640 [CrossRef] [PubMed]
    [Google Scholar]
  16. Vercelli A, Mereuta OM, Garbossa D, Muraca G, Mareschi K et al. Human mesenchymal stem cell transplantation extends survival, improves motor performance and decreases neuroinflammation in mouse model of amyotrophic lateral sclerosis. Neurobiol Dis 2008; 31: 395– 405 [CrossRef] [PubMed]
    [Google Scholar]
  17. Zhou C, Zhang C, Zhao R, Chi S, Ge P et al. Human marrow stromal cells reduce microglial activation to protect motor neurons in a transgenic mouse model of amyotrophic lateral sclerosis. J Neuroinflammation 2013; 10: 52 [CrossRef] [PubMed]
    [Google Scholar]
  18. Honmou O, Houkin K, Matsunaga T, Niitsu Y, Ishiai S et al. Intravenous administration of auto serum-expanded autologous mesenchymal stem cells in stroke. Brain 2011; 134: 1790– 1807 [CrossRef] [PubMed]
    [Google Scholar]
  19. Yoon SH, Shim YS, Park YH, Chung JK, Nam JH et al. Complete spinal cord injury treatment using autologous bone marrow cell transplantation and bone marrow stimulation with granulocyte macrophage-colony stimulating factor: phase I/II clinical trial. Stem Cells 2007; 25: 2066– 2073 [CrossRef] [PubMed]
    [Google Scholar]
  20. Karussis D, Karageorgiou C, Vaknin-Dembinsky A, Gowda-Kurkalli B, Gomori JM et al. Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis. Arch Neurol 2010; 67: 1187– 1194 [CrossRef] [PubMed]
    [Google Scholar]
  21. Ohtaki H, Ylostalo JH, Foraker JE, Robinson AP, Reger RL et al. Stem/progenitor cells from bone marrow decrease neuronal death in global ischemia by modulation of inflammatory/immune responses. Proc Natl Acad Sci USA 2008; 105: 14638– 14643 [CrossRef] [PubMed]
    [Google Scholar]
  22. Chopp M, Li Y. Treatment of neural injury with marrow stromal cells. Lancet Neurol 2002; 1: 92– 100 [CrossRef] [PubMed]
    [Google Scholar]
  23. Bai L, Lennon DP, Caplan AI, Dechant A, Hecker J et al. Hepatocyte growth factor mediates mesenchymal stem cell–induced recovery in multiple sclerosis models. Nat Neurosci 2012; 15: 862– 870 [CrossRef] [PubMed]
    [Google Scholar]
  24. Munoz JR, Stoutenger BR, Robinson AP, Spees JL, Prockop DJ. Human stem/progenitor cells from bone marrow promote neurogenesis of endogenous neural stem cells in the hippocampus of mice. Proc Natl Acad Sci USA 2005; 102: 18171– 18176 [CrossRef] [PubMed]
    [Google Scholar]
  25. Dezawa M, Kanno H, Hoshino M, Cho H, Matsumoto N et al. Specific induction of neuronal cells from bone marrow stromal cells and application for autologous transplantation. J Clin Invest 2004; 113: 1701– 1710 [CrossRef] [PubMed]
    [Google Scholar]
  26. Woodbury D, Schwarz EJ, Prockop DJ, Black IB. Adult rat and human bone marrow stromal cells differentiate into neurons. J Neurosci Res 2000; 61: 364– 370 [CrossRef] [PubMed]
    [Google Scholar]
  27. Toyama K, Honmou O, Harada K, Suzuki J, Houkin K et al. Therapeutic benefits of angiogenetic gene-modified human mesenchymal stem cells after cerebral ischemia. Exp Neurol 2009; 216: 47– 55 [CrossRef] [PubMed]
    [Google Scholar]
  28. Calió ML, Marinho DS, Ko GM, Ribeiro RR, Carbonel AF et al. Transplantation of bone marrow mesenchymal stem cells decreases oxidative stress, apoptosis, and hippocampal damage in brain of a spontaneous stroke model. Free Radic Biol Med 2014; 70: 141– 154 [CrossRef] [PubMed]
    [Google Scholar]
  29. Song CH, Honmou O, Ohsawa N, Nakamura K, Hamada H et al. Effect of transplantation of bone marrow-derived mesenchymal stem cells on mice infected with prions. J Virol 2009; 83: 5918– 5927 [CrossRef] [PubMed]
    [Google Scholar]
  30. Horiuchi M, Priola SA, Chabry J, Caughey B. Interactions between heterologous forms of prion protein: binding, inhibition of conversion, and species barriers. Proc Natl Acad Sci USA 2000; 97: 5836– 5841 [CrossRef] [PubMed]
    [Google Scholar]
  31. Prusiner SB, Scott M, Foster D, Pan KM, Groth D et al. Transgenetic studies implicate interactions between homologous PrP isoforms in scrapie prion replication. Cell 1990; 63: 673– 686 [CrossRef] [PubMed]
    [Google Scholar]
  32. Priola SA, Caughey B, Race RE, Chesebro B. Heterologous PrP molecules interfere with accumulation of protease-resistant PrP in scrapie-infected murine neuroblastoma cells. J Virol 1994; 68: 4873– 4878 [PubMed]
    [Google Scholar]
  33. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143– 147 [CrossRef] [PubMed]
    [Google Scholar]
  34. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006; 8: 315– 317 [CrossRef] [PubMed]
    [Google Scholar]
  35. Ren G, Zhao X, Zhang L, Zhang J, L'Huillier A et al. Inflammatory cytokine-induced intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in mesenchymal stem cells are critical for immunosuppression. J Immunol 2010; 184: 2321– 2328 [CrossRef] [PubMed]
    [Google Scholar]
  36. Yang ZX, Han ZB, Ji YR, Wang YW, Liang L et al. CD106 identifies a subpopulation of mesenchymal stem cells with unique immunomodulatory properties. PLoS One 2013; 8: e59354 [CrossRef] [PubMed]
    [Google Scholar]
  37. Kim TE, Kim CG, Kim JS, Jin S, Yoon S et al. Three-dimensional culture and interaction of cancer cells and dendritic cells in an electrospun nano-submicron hybrid fibrous scaffold. Int J Nanomedicine 2016; 11: 823– 835 [CrossRef] [PubMed]
    [Google Scholar]
  38. Song CH, Honmou O, Furuoka H, Horiuchi M. Identification of chemoattractive factors involved in the migration of bone marrow-derived mesenchymal stem cells to brain lesions caused by prions. J Virol 2011; 85: 11069– 11078 [CrossRef] [PubMed]
    [Google Scholar]
  39. Song CH, Furuoka H, Kim CL, Ogino M, Suzuki A et al. Effect of intraventricular infusion of anti-prion protein monoclonal antibodies on disease progression in prion-infected mice. J Gen Virol 2008; 89: 1533– 1544 [CrossRef] [PubMed]
    [Google Scholar]
  40. Ohsawa N, Song CH, Suzuki A, Furuoka H, Hasebe R et al. Therapeutic effect of peripheral administration of an anti-prion protein antibody on mice infected with prions. Microbiol Immunol 2013; 57: 288– 297 [CrossRef] [PubMed]
    [Google Scholar]
  41. Kuroda Y, Wakao S, Kitada M, Murakami T, Nojima M et al. Isolation, culture and evaluation of multilineage-differentiating stress-enduring (Muse) cells. Nat Protoc 2013; 8: 1391– 1415 [CrossRef] [PubMed]
    [Google Scholar]
  42. Houlihan DD, Mabuchi Y, Morikawa S, Niibe K, Araki D et al. Isolation of mouse mesenchymal stem cells on the basis of expression of Sca-1 and PDGFR-α. Nat Protoc 2012; 7: 2103– 2111 [CrossRef] [PubMed]
    [Google Scholar]
  43. Sasaki A, Hirato J, Nakazato Y. Immunohistochemical study of microglia in the Creutzfeldt-Jakob diseased brain. Acta Neuropathol 1993; 86: 337– 344 [CrossRef] [PubMed]
    [Google Scholar]
  44. Williams AE, Lawson LJ, Perry VH, Fraser H. Characterization of the microglial response in murine scrapie. Neuropathol Appl Neurobiol 1994; 20: 47– 55 [CrossRef] [PubMed]
    [Google Scholar]
  45. Williams A, Lucassen PJ, Ritchie D, Bruce M. PrP deposition, microglial activation, and neuronal apoptosis in murine scrapie. Exp Neurol 1997; 144: 433– 438 [CrossRef] [PubMed]
    [Google Scholar]
  46. Gómez-Nicola D, Fransen NL, Suzzi S, Perry VH. Regulation of microglial proliferation during chronic neurodegeneration. J Neurosci 2013; 33: 2481– 2493 [CrossRef] [PubMed]
    [Google Scholar]
  47. Burwinkel M, Schwarz A, Riemer C, Schultz J, van Landeghem F et al. Rapid disease development in scrapie-infected mice deficient for CD40 ligand. EMBO Rep 2004; 5: 527– 531 [CrossRef] [PubMed]
    [Google Scholar]
  48. Falsig J, Julius C, Margalith I, Schwarz P, Heppner FL et al. A versatile prion replication assay in organotypic brain slices. Nat Neurosci 2008; 11: 109– 117 [CrossRef] [PubMed]
    [Google Scholar]
  49. Zhu C, Herrmann US, Falsig J, Abakumova I, Nuvolone M et al. A neuroprotective role for microglia in prion diseases. J Exp Med 2016; 213: 1047– 1059 [CrossRef] [PubMed]
    [Google Scholar]
  50. Sakai K, Hasebe R, Takahashi Y, Song CH, Suzuki A et al. Absence of CD14 delays progression of prion diseases accompanied by increased microglial activation. J Virol 2013; 87: 13433– 13445 [CrossRef] [PubMed]
    [Google Scholar]
  51. El Khoury J, Toft M, Hickman SE, Means TK, Terada K et al. Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease. Nat Med 2007; 13: 432– 438 [CrossRef] [PubMed]
    [Google Scholar]
  52. Hickman SE, Allison EK, El Khoury J. Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer's disease mice. J Neurosci 2008; 28: 8354– 8360 [CrossRef] [PubMed]
    [Google Scholar]
  53. Koenigsknecht-Talboo J, Landreth GE. Microglial phagocytosis induced by fibrillar β-amyloid and IgGs are differentially regulated by proinflammatory cytokines. J Neurosci 2005; 25: 8240– 8249 [CrossRef] [PubMed]
    [Google Scholar]
  54. Campbell IL, Eddleston M, Kemper P, Oldstone MB, Hobbs MV. Activation of cerebral cytokine gene expression and its correlation with onset of reactive astrocyte and acute-phase response gene expression in scrapie. J Virol 1994; 68: 2383– 2387 [PubMed]
    [Google Scholar]
  55. Kordek R, Nerurkar VR, Liberski PP, Isaacson S, Yanagihara R et al. Heightened expression of tumor necrosis factor alpha, interleukin 1 alpha, and glial fibrillary acidic protein in experimental Creutzfeldt-Jakob disease in mice. Proc Natl Acad Sci USA 1996; 93: 9754– 9758 [CrossRef] [PubMed]
    [Google Scholar]
  56. Hwang D, Lee IY, Yoo H, Gehlenborg N, Cho JH et al. A systems approach to prion disease. Mol Syst Biol 2009; 5: 252 [CrossRef] [PubMed]
    [Google Scholar]
  57. Hughes MM, Field RH, Perry VH, Murray CL, Cunningham C. Microglia in the degenerating brain are capable of phagocytosis of beads and of apoptotic cells, but do not efficiently remove PrPSc, even upon LPS stimulation. Glia 2010; 58: 2017– 2030 [CrossRef] [PubMed]
    [Google Scholar]
  58. Konala VB, Mamidi MK, Bhonde R, das AK, Pochampally R et al. The current landscape of the mesenchymal stromal cell secretome: a new paradigm for cell-free regeneration. Cytotherapy 2016; 18: 13– 24 [CrossRef] [PubMed]
    [Google Scholar]
  59. Salem HK, Thiemermann C. Mesenchymal stromal cells: current understanding and clinical status. Stem Cells 2010; 28: 585– 596 [CrossRef] [PubMed]
    [Google Scholar]
  60. Kyurkchiev D, Bochev I, Ivanova-Todorova E, Mourdjeva M, Oreshkova T et al. Secretion of immunoregulatory cytokines by mesenchymal stem cells. World J Stem Cells 2014; 6: 552– 570 [CrossRef] [PubMed]
    [Google Scholar]
  61. Kim KS, Kim HS, Park JM, Kim HW, Park MK et al. Long-term immunomodulatory effect of amniotic stem cells in an Alzheimer's disease model. Neurobiol Aging 2013; 34: 2408– 2420 [CrossRef] [PubMed]
    [Google Scholar]
  62. Naaldijk Y, Jäger C, Fabian C, Leovsky C, Blüher A et al. Effect of systemic transplantation of bone marrow-derived mesenchymal stem cells on neuropathology markers in APP/PS1 Alzheimer mice. Neuropathol Appl Neurobiol 2017; 43: 299– 314 [CrossRef] [PubMed]
    [Google Scholar]
  63. Zhang YK, Liu JT, Peng ZW, Fan H, Yao AH et al. Different TLR4 expression and microglia/macrophage activation induced by hemorrhage in the rat spinal cord after compressive injury. J Neuroinflammation 2013; 10: 112 [CrossRef] [PubMed]
    [Google Scholar]
  64. Chio CC, Lin MT, Chang CP. Microglial activation as a compelling target for treating acute traumatic brain injury. Curr Med Chem 2015; 22: 759– 770 [CrossRef] [PubMed]
    [Google Scholar]
  65. Zhu H, Guo ZK, Jiang XX, Li H, Wang XY et al. A protocol for isolation and culture of mesenchymal stem cells from mouse compact bone. Nat Protoc 2010; 5: 550– 560 [CrossRef] [PubMed]
    [Google Scholar]
  66. Shindoh R, Kim CL, Song CH, Hasebe R, Horiuchi M. The region approximately between amino acids 81 and 137 of proteinase K-resistant PrPSc is critical for the infectivity of the Chandler prion strain. J Virol 2009; 83: 3852– 3860 [CrossRef] [PubMed]
    [Google Scholar]
  67. Furuoka H, Yabuzoe A, Horiuchi M, Tagawa Y, Yokoyama T et al. Effective antigen-retrieval method for immunohistochemical detection of abnormal isoform of prion proteins in animals. Acta Neuropathol 2005; 109: 263– 271 [CrossRef] [PubMed]
    [Google Scholar]
  68. Kim CL, Umetani A, Matsui T, Ishiguro N, Shinagawa M et al. Antigenic characterization of an abnormal isoform of prion protein using a new diverse panel of monoclonal antibodies. Virology 2004; 320: 40– 51 [CrossRef] [PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/jgv.0.000907
Loading
/content/journal/jgv/10.1099/jgv.0.000907
Loading

Data & Media loading...

Supplements

Supplementary File 1

PDF

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error